Raid Captures 82 Million Doses of Counterfeit Drugs in Africa - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Raid Captures 82 Million Doses of Counterfeit Drugs in Africa


ePT--the Electronic Newsletter of Pharmaceutical Technology

An operation spanning 16 African countries and conducted by the World Customs Organization (WCO) in partnership with the Institute of Research against Counterfeit Medicines (IRACM) led to the seizure of more than 82 million doses of counterfeit medicines. The drugs seized included antimalarials, antibiotics, cough medicines, contraceptive pills, and fertility treatments, and were valued at around $40 million.

The operation was conducted simultaneously at 16 major seaports on the east and west coasts of Africa between July 11, 2012, and July 20, 2012. Customs officials seized more than 100 million counterfeit products of all categories. Of a total of 110 shipping containers inspected, 84 contained counterfeit or illegal products, with the largest shipments found in Angola, Togo, Cameroon, and Ghana. The majority of the shipments originated from South Asia, East Asia, and the Middle East.

According to a joint press release from IRACM and WCO, customs officers involved were trained by WCO, with the support of IRACM and experts from the pharmaceutical sector, to recognize the technical characteristics of various products that are subject to counterfeiting and to implement new detection methods. According to the release, the organizations expect to extend the operation to other continents in the coming months.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
100%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
0%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Key Ways for Ensuring Global Regulatory Compliance
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here